Q3 2024 Holdings
Filed 2024-11-14 | 44 holdings | $599.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Harrow Health Inc(HROW) | COM | 415858109 | $179.4M | 3,990,000 | 29.9% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $53.3M | 2,280,000 | 8.9% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $43.7M | 5,025,000 | 7.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $30.9M | 1,255,000 | 5.2% |
| Codexis Inc(CDXS) | COM | 192005106 | $27.0M | 8,770,000 | 4.5% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $26.2M | 500,000 | 4.4% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $23.0M | 395,276 | 3.8% |
| Immunome Inc(IMNM) | COM | 45257U108 | $18.1M | 1,237,500 | 3.0% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $17.0M | 1,698,142 | 2.8% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $16.7M | 2,780,000 | 2.8% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $13.9M | 522,500 | 2.3% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $11.8M | 541,437 | 2.0% |
| Applied Therapeutics Inc'(APLT) | COM | 03828A101 | $11.2M | 1,320,000 | 1.9% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $9.7M | 85,000 | 1.6% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $9.4M | 420,000 | 1.6% |
| Acelyrin Inc | COM | 00445A100 | $9.3M | 1,893,660 | 1.6% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $8.6M | 2,567,990 | 1.4% |
| Biodesix Inc | COM | 09075X108 | $7.0M | 3,815,000 | 1.2% |
| Ginkgo Bioworks Holdings(DNA) | Class A New | 37611X209 | $6.7M | 820,202 | 1.1% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $6.6M | 353,500 | 1.1% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $6.6M | 250,000 | 1.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $6.5M | 64,000 | 1.1% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $5.6M | 335,000 | 0.9% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $5.1M | 404,100 | 0.9% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $4.7M | 105,000 | 0.8% |
| Gossamer BIO Inc | NOTE 5.000% 6/0 | 38341PAA0 | $4.2M | $8,000,000 | 0.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $4.0M | 75,300 | 0.7% |
| Karyopharm Therapeutics Inc | NOTE 3.000%10/1 | 48576UAA4 | $4.0M | $6,000,000 | 0.7% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $3.7M | 3,665,010 | 0.6% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $3.6M | 967,000 | 0.6% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $3.1M | 1,681,154 | 0.5% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $2.3M | 466,563 | 0.4% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $2.2M | 112,500 | 0.4% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $2.1M | 800,000 | 0.3% |
| Lyell Immunopharma Inc | COM | 55083R104 | $1.9M | 1,395,000 | 0.3% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $1.6M | 2,407,600 | 0.3% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $1.6M | 480,000 | 0.3% |
| Pepgen Inc(PEPG) | COM | 713317105 | $1.5M | 179,200 | 0.3% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $1.4M | 275,000 | 0.2% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $1.4M | 654,943 | 0.2% |
| Aerovate Therapeutics Inc | COM | 008064107 | $919.6K | 440,000 | 0.2% |
| Regulus Therapeutics Inc(RGLS) | COM | 75915K309 | $840.0K | 535,000 | 0.1% |
| Ibio Inc(IBIO) | COM NEW | 451033708 | $832.5K | 375,000 | 0.1% |
| Adagio MED Hldgs Inc(ADGM) | COM | 00534B100 | $285.3K | 110,571 | 0.0% |